Drug intelligence / Profile preview

hemopexin-heme complex

Development stage
Preclinical
Lead developer
CSL Behring
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

**Hemopexin-heme complex** is the high-affinity complex formed when the plasma heme-scavenger protein hemopexin binds free heme. In preclinical sickle cell disease models, intravenously administered equimolar hemopexin-heme complex reduced hemoglobin-triggered microvascular stasis, although less effectively than heme-free hemopexin. The complex renders heme relatively nonreactive, limits heme-driven Toll-like receptor 4 inflammatory signaling, and is cleared through low-density lipoprotein receptor-related protein 1-mediated uptake, with intracellular heme processing that can induce heme oxygenase-1 and generate cytoprotective metabolites. ([ashpublications.org](https://ashpublications.org/blood/article/136/Supplement%201/9/472271/Microvascular-Stasis-Inhibition-By-Hemopexin-in))

Other names
heme-hemopexin complexhemopexin-hemehemopexin-heme complex
02

Targets

Heme (Free extracellular heme)LRP1 (Prolow-density lipoprotein receptor-related protein 1)

Beyond the preview

Go deeper on hemopexin-heme complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hemopexin-heme complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call